Key result
Genetically predicted obstructive sleep apnea is linked to ~21% higher risk of atrial fibrillation.
Why the study?
Observational studies show obstructive sleep apnea is associated with increased atrial fibrillation risk, but whether this reflects a causal effect remains unclear.
Does genetically predicted obstructive sleep apnea causally increase the risk of atrial fibrillation?
Does genetically predicted obstructive sleep apnea causally increase the risk of atrial fibrillation?
Answers are grounded in this paper and cite their sources.
This 2-sample Mendelian randomization study provides genetic evidence supporting a causal effect of obstructive sleep apnea on increased risk of atrial fibrillation, reinforcing the clinical value of OSA screening and management for AF prevention.
Background Obstructive sleep apnea (OSA) has shown to be associated with an increased risk of atrial fibrillation in observational studies. Whether this association reflect causal effect is still unclear. The aim of this study was to evaluate the causal effect of OSA on atrial fibrillation. Methods and Results We used a 2‐sample Mendelian randomization (MR) method to evaluate the causal effect of OSA on atrial fibrillation. Summary data on genetic variant‐OSA association were obtained from a recently published genome‐wide association studies with up to 217 955 individuals and data on variant‐atrial fibrillation association from another genome‐wide association study with up to 1 030 836 individuals. Effect estimates were evaluated using inverse‐variance weighted method. Other MR analyses, including penalized inverse‐variance weighted, penalized robust inverse‐variance weighted, MR‐Egger, simple median, weighted median, weighted mode‐based estimate and Mendelian Randomization Pleiotropy Residual Sum and Outlier methods were performed in sensitivity analyses. The MR analyses in both the fixed‐effect and random‐effect inverse‐variance weighted models showed that genetically predicted OSA was associated with an increased risk of atrial fibrillation (odds ratio [OR], 1.21; 95% CI, 1.12–1.31, P <0.001; OR, 1.21; 95% CI, 1.11–1.32, P <0.001) using 5 single nucleotide polymorphisms as the instruments. MR‐Egger indicated no evidence of genetic pleiotropy (intercept, −0.014; 95% CI, −0.033 to 0.005, P =0.14). Results were robust using other MR methods in sensitivity analyses. Conclusions This MR analysis found that genetically predicted OSA had causal effect on an increased risk of atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied Obstructive sleep apnea and atrial fibrillation (n=1,030,836). Genetically predicted obstructive sleep apnea (per 1-unit-higher log-odds using 5 SNPs) vs. Reference genetic risk (lower log-odds of obstructive sleep apnea) was evaluated on Risk of atrial fibrillation (diagnosed mainly by ICD-9 or ICD-10) (OR 1.21, 95% CI 1.12–1.31, p=<0.001). Genetically predicted obstructive sleep apnea was causally associated with an increased risk of atrial fibrillation (OR 1.21, 95% CI 1.12–1.31, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: